1. Home
  2. AUPH vs TUYA Comparison

AUPH vs TUYA Comparison

Compare AUPH & TUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • TUYA
  • Stock Information
  • Founded
  • AUPH 1993
  • TUYA 2014
  • Country
  • AUPH Canada
  • TUYA China
  • Employees
  • AUPH N/A
  • TUYA N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • TUYA Computer Software: Prepackaged Software
  • Sector
  • AUPH Health Care
  • TUYA Technology
  • Exchange
  • AUPH Nasdaq
  • TUYA Nasdaq
  • Market Cap
  • AUPH 1.1B
  • TUYA 1.6B
  • IPO Year
  • AUPH 1999
  • TUYA 2021
  • Fundamental
  • Price
  • AUPH $8.86
  • TUYA $2.44
  • Analyst Decision
  • AUPH Strong Buy
  • TUYA
  • Analyst Count
  • AUPH 2
  • TUYA 0
  • Target Price
  • AUPH $11.50
  • TUYA N/A
  • AVG Volume (30 Days)
  • AUPH 1.9M
  • TUYA 1.9M
  • Earning Date
  • AUPH 07-31-2025
  • TUYA 08-25-2025
  • Dividend Yield
  • AUPH N/A
  • TUYA 2.48%
  • EPS Growth
  • AUPH N/A
  • TUYA N/A
  • EPS
  • AUPH 0.27
  • TUYA 0.03
  • Revenue
  • AUPH $247,295,000.00
  • TUYA $311,642,000.00
  • Revenue This Year
  • AUPH $12.15
  • TUYA $11.65
  • Revenue Next Year
  • AUPH $18.31
  • TUYA $13.06
  • P/E Ratio
  • AUPH $33.04
  • TUYA $75.16
  • Revenue Growth
  • AUPH 29.20
  • TUYA 27.64
  • 52 Week Low
  • AUPH $5.20
  • TUYA $1.28
  • 52 Week High
  • AUPH $10.67
  • TUYA $4.63
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 64.10
  • TUYA 48.87
  • Support Level
  • AUPH $7.36
  • TUYA $2.42
  • Resistance Level
  • AUPH $9.10
  • TUYA $2.59
  • Average True Range (ATR)
  • AUPH 0.44
  • TUYA 0.10
  • MACD
  • AUPH 0.10
  • TUYA 0.01
  • Stochastic Oscillator
  • AUPH 89.53
  • TUYA 59.72

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About TUYA Tuya Inc. each representing one

Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, it has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.

Share on Social Networks: